Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dilip Shanghvi
Asia
Sun Pharma chief, Dr. Reddy's, Natco and more—FiercePharmaAsia
Sun's Shanghvi took a 99% pay cut last year. Dr. Reddy's copies of Copaxone and NuvaRing were rejected by the FDA. Natco eyes China amid hardship.
Angus Liu
Aug 16, 2019 10:30am
Sun's Shanghvi took just Rs 1 in salary amid governance struggle
Aug 13, 2019 10:36am
Takeda-Novartis, Daiichi-AZ and more—FiercePharmaAsia
May 10, 2019 9:45am
Sun Pharma bows to investor pressure for changes
Jan 22, 2019 11:01am
Sun Pharma hit by another whistleblower complaint
Jan 18, 2019 9:27am
Indian regulators confirm whistleblower complaint against Sun
Dec 13, 2018 12:13pm
